Publication:
Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.

dc.contributor.authorLeon-Acuña, A
dc.contributor.authorAlcala-Diaz, J F
dc.contributor.authorDelgado-Lista, J
dc.contributor.authorTorres-Peña, J D
dc.contributor.authorLopez-Moreno, J
dc.contributor.authorCamargo, A
dc.contributor.authorGarcia-Rios, A
dc.contributor.authorMarin, C
dc.contributor.authorGomez-Delgado, F
dc.contributor.authorCaballero, J
dc.contributor.authorVan-Ommen, B
dc.contributor.authorMalagon, M M
dc.contributor.authorPerez-Martinez, P
dc.contributor.authorLopez-Miranda, J
dc.contributor.funderJunta de Andalucia (Consejeria de Salud, Consejeria de Agricultura y Pesca, Consejeria de Innovacion, Ciencia y Empresa)
dc.contributor.funderMinisterio de Ciencia e Innovacion
dc.contributor.funderMinisterio de Economia y Competitividad
dc.contributor.funderConsejeria de Salud, Junta de Andalucia
dc.date.accessioned2023-01-25T08:31:50Z
dc.date.available2023-01-25T08:31:50Z
dc.date.issued2016-03-30
dc.description.abstractPrevious evidences have shown the presence of a prolonged and exaggerated postprandial response in type 2 diabetes mellitus (T2DM) and its relation with an increase of cardiovascular risk. However, the response in prediabetes population has not been established. The objective was to analyze the degree of postprandial lipemia response in the CORDIOPREV clinical trial (NCT00924937) according to the diabetic status. 1002 patients were submitted to an oral fat load test meal (OFTT) with 0.7 g fat/kg body weight [12 % saturated fatty acids (SFA), 10 % polyunsaturated fatty acids (PUFA), 43 % monounsaturated fatty acids (MUFA), 10 % protein and 25 % carbohydrates]. Serial blood test analyzing lipid fractions were drawn at 0, 1, 2, 3 and 4 h during postprandial state. Postprandial triglycerides (TG) concentration at any point >2.5 mmol/L (220 mg/dL) has been established as undesirable response. We explored the dynamic response in 57 non-diabetic, 364 prediabetic and 581 type 2 diabetic patients. Additionally, the postprandial response was evaluated according to basal insulin resistance subgroups in patients non-diabetic and diabetic without pharmacological treatment (N = 642). Prevalence of undesirable postprandial TG was 35 % in non-diabetic, 48 % in prediabetic and 59 % in diabetic subgroup, respectively (p Our findings demonstrate that prediabetic patients show a lower phenotypic flexibility after external aggression, such as OFTT compared with nondiabetic patients. The postprandial response increases progressively according to non-diabetic, prediabetic and type 2 diabetic state and it is higher in patients with liver insulin-resistance. To identify this subgroup of patients is important to treat more intensively in order to avoid future cardiometabolic complications.
dc.description.versionSi
dc.identifier.citationLeon-Acuña A, Alcala-Diaz JF, Delgado-Lista J, Torres-Peña JD, Lopez-Moreno J, Camargo A, et al. Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study. Cardiovasc Diabetol. 2016 Apr 19;15:68
dc.identifier.doi10.1186/s12933-016-0380-y
dc.identifier.essn1475-2840
dc.identifier.pmcPMC4837552
dc.identifier.pmid27095446
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837552/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1186/s12933-016-0380-y
dc.identifier.urihttp://hdl.handle.net/10668/10003
dc.journal.titleCardiovascular diabetology
dc.journal.titleabbreviationCardiovasc Diabetol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number10
dc.publisherBioMed Central
dc.pubmedtypeJournal Article
dc.pubmedtypeRandomized Controlled Trial
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDAGL2009-122270
dc.relation.projectIDPI10/01041
dc.relation.projectIDAGL2012/39615
dc.relation.projectIDPI0193/09
dc.relation.publisherversionhttps://cardiab.biomedcentral.com/articles/10.1186/s12933-016-0380-y
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCORDIOPREV study
dc.subjectInsulin resistance
dc.subjectPhenotypic flexibility
dc.subjectPostprandial lipemia
dc.subjectPrediabetic
dc.subjectTriglycerides
dc.subject.decsDiabetes mellitus tipo 2
dc.subject.decsEstado prediabético
dc.subject.decsGlucemia
dc.subject.decsHipertrigliceridemia
dc.subject.decsInsulina
dc.subject.decsObesidad
dc.subject.decsPeriodo posprandial
dc.subject.decsResistencia a la insulina
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshBlood glucose
dc.subject.meshDiabetes mellitus, type 2
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshHypertriglyceridemia
dc.subject.meshInsulin
dc.subject.meshInsulin resistance
dc.subject.meshLipids
dc.subject.meshLiver
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshObesity
dc.subject.meshPostprandial period
dc.subject.meshPrediabetic state
dc.subject.meshRisk factors
dc.subject.meshTriglycerides
dc.titleHepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number15
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC4837552.pdf
Size:
1.26 MB
Format:
Adobe Portable Document Format